Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-17

Clinical Trial Update: Controlled Study of the Ability of a Smokefree Tobacco Product to Increase the Quit Rate Among Cigarette Smokers [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial evaluating whether a smokefree tobacco product can increase quit rates among cigarette smokers. Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Smokefree tobacco product

Snippet

Sponsor: Swedish Match AB | Conditions: Cigarette Smoking | Phase 4 | Status: COMPLETED | Results posted: 2014-06-17